ADC THERAPEUTICS

ADC Therapeutics is a clinical-stage oncology drug discovery and development company focused on advancing highly potent and targeted antibody-drug conjugates (ADCs) for the treatment of hematological cancers and solid tumors. Their ADCs are developed using the latest-generation pyrrolobenzodiazepine (PBD) dimer technology providing a superior therapeutic index compared to first-generation PBD ADCs in preclinical studies. PBD dimers are very potent toxins that actively kill cancer cells and have a differentiated mechanism of action than warheads commonly used in other ADCs.

#People #Financial #Event #Website #More

ADC THERAPEUTICS

Social Links:

Facebook

Twitter

Industry:

Biopharma Biotechnology Medical Therapeutics

Founded:

2011-01-01

Address:

Lausanne, Vaud, Switzerland

Country:

Switzerland

Website Url:

http://www.adctherapeutics.com

Total Employee:

251+

Status:

Active

Contact:

+1 908-731-5556

Email Addresses:

[email protected]

Total Funding:

691.55 M USD

Technology used in webpage:

Nginx Microsoft Exchange Online Amazon ReCAPTCHA Cloudflare Person Schema Cloudflare Hosting Gravatar Profiles Apple Mobile Web App Capable Cloudflare SSL

Current Advisors List

stephen-evans-freke_image

Stephen Evans-Freke Board Member @ ADC Therapeutics
Board_member
2012-03-01

michael-forer_image

Michael Forer Board Member @ ADC Therapeutics
Board_member
2012-03-01

not_available_image

Barrie Ward Board Member @ ADC Therapeutics
Board_member

not_available_image

Samuel Broder Board Member @ ADC Therapeutics
Board_member
2012-03-01

peter-corr_image

Peter Corr Board Member @ ADC Therapeutics
Board_member
2012-03-01

ron-squarer_image

Ron Squarer Chairman & Advisor, ADC Therapeutics @ ADC Therapeutics
Board_member
2020-03-01

christopher-martin_image

Christopher Martin Board Member @ ADC Therapeutics
Board_member
2022-05-01

Current Employees Featured

liangyi-zhang_image

Liangyi Zhang
Liangyi Zhang Associate Director, CMC Analytical @ ADC Therapeutics
Associate Director, CMC Analytical
2017-05-01

michael-forer_image

Michael Forer
Michael Forer Vice Chairman and Executive Vice President @ ADC Therapeutics
Vice Chairman and Executive Vice President

jens-würthner_image

Jens Würthner
Jens Würthner Head of Clinical Development – EU @ ADC Therapeutics
Head of Clinical Development – EU

jay-feingold_image

Jay Feingold
Jay Feingold Senior Vice President, Chief Medical Officer & Head of Oncology Clinical Development @ ADC Therapeutics
Senior Vice President, Chief Medical Officer & Head of Oncology Clinical Development

kimberly-pope_image

Kimberly Pope
Kimberly Pope Chief Human Resources Officer @ ADC Therapeutics
Chief Human Resources Officer
2020-08-01

ameet-mallik_image

Ameet Mallik
Ameet Mallik President & CEO @ ADC Therapeutics
President & CEO
2022-05-01

david-gilman_image

David Gilman
David Gilman Chief Business & Strategy Officer @ ADC Therapeutics
Chief Business & Strategy Officer
2022-01-01

victor-sandor_image

Victor Sandor
Victor Sandor Independent Director @ ADC Therapeutics
Independent Director
2020-04-01

oscar-segurado_image

Oscar Segurado
Oscar Segurado Chief Medical Officer @ ADC Therapeutics
Chief Medical Officer
2019-12-01

susan-romanus_image

Susan Romanus
Susan Romanus Chief Compliance Officer @ ADC Therapeutics
Chief Compliance Officer
2018-06-01

Founder

christopher-martin_image

Christopher Martin

Stock Details

Company's stock symbol is NYSE:ADCT

Investors List

deerfield_image

Key Employee Changes

Date	New article
2022-06-13	ADC Therapeutics Names David Gilman as Chief Business & Strategy Officer
2022-05-09	ADC Therapeutics Announces CEO Transition
2020-04-21	ADC Therapeutics Appoints Jennifer Creel as Chief Financial Officer

Official Site Inspections

http://www.adctherapeutics.com Semrush global rank: 2.17 M Semrush visits lastest month: 9.11 K

Host Informations
Whois Informations

Loading ...